Cemex S.A.B. de C.V. Sponsored ADR vs Tempus AI — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.56 (market cap $13.79B), while Tempus AI trades at $70.25 (market cap $12.58B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR and Tempus AI are close in size by market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Tempus AI for 22 Days on average.
| CX | TEM | |
|---|---|---|
Market Cap | $13.79B | $12.58B |
Volume | 3,993,982 | 7,444,569 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $13.55 | $99.28 |
52-Week Low | $9.12 | $41.55 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $19.79B | $13.21B |
Dividend Yield | 1.3% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →